Montelukast Tablets 10mg

Montelukast is indicated for the treatment of asthma as add-on therapy in patients with mild to moderate persistent asthma who are not adequately controlled with inhaled corticosteroids and in whom "as-needed" short-acting ß-agonists provide insufficient asthma control. Montelukast can also be an alternative treatment option to low-dose inhaled corticosteroids for patients aged 2 to 14 years with mild persistent asthma who do not have a recent history of severe asthma attacks requiring oral corticosteroids and have demonstrated an inability to use inhaled corticosteroids.

icono forma farmaceutica
Pharmaceutical form

Tablet

icono concentracion
Concentration

icono combinacion
Combination

N/A

Disclaimer: The content of this website is for pharmaceutical industry professionals interested in creating a strategic alliance with Wexford Laboratories. This page may contain information related to health, medical conditions, physical condition and its treatment. The information contained in this site is not to diagnose a health problem and is not a substitute for the advice provided by your doctor. Always consult a doctor when in doubt about a disease and its treatment. The products are subject to the applicable patent and registration laws of each country, and may not be allowed to be registered in some markets.

Open chat
[caldera_form id="CF64ee16c372d21"]